13D Filing: Baker Bros. Advisors and Mirati Therapeutics Inc. (MRTX)
...... (read more)
Mirati Therapeutics Inc. (MRTX)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Broadfin Capital Kevin Kotler | 2,447,746 | $44,671 | -2% | 7.3% |
| 2. | VenBio Select Advisor Kurt Von Emster | 4,398,101 | $80,265 | +19% | 5.2% |
| 3. | Ghost Tree Capital Ken Greenberg And David Kim | 600,000 | $10,950 | 2.56% | |
| 4. | Cormorant Asset Management Bihua Chen | 1,231,522 | $22,475 | +24% | 2.35% |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,549,461 | $46,528 | +13% | 0.4% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.00 | 255,264 | Large Shareholder | 3,135,966 | 2017-11-16 | Filing | |
| $13.00 | 144,736 | Large Shareholder | 1,372,510 | 2017-11-16 | Filing | |
| $13.00 | 650,000 | Large Shareholder | 4,360,601 | 2017-11-16 | Filing | |
| $5.45 | 28,839 | Large Shareholder | 2,880,702 | 2017-01-26 | Filing | |
| $5.44 | 19,330 | Large Shareholder | 2,851,863 | 2017-01-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.00 | 12,100 | 0 | 2018-03-09 | Filing | ||
| $28.08 | 500 | 0 | 2018-03-01 | Filing | ||
| $27.45 | 25,775 | 500 | 2018-03-01 | Filing | ||
| $26.78 | 25,600 | 26,275 | 2018-03-01 | Filing | ||
| $28.56 | 11,062 | 50,932 | 2018-02-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 9,744 | $299 | 0.07% | |
| 2. | 528,396 | $16,222 | 0.01% | |
| 3. | 1,400 | $43 | 0% | |
| 4. | 1,400 | $43 | 0% | |
| 5. | 7,562 | $232 | 0% |
News See All
13G Filing: VenBio Select Advisor and Mirati Therapeutics Inc. (MRTX)
This statement is filed by: (i) venBio Select Advisor LLC, a Delaware limited liability company (“venBio”), which provides investment advisory and management services and has acquired the securities...... (read more)
Is Mirati Therapeutics, Inc. (MRTX) Going to Burn These Hedge Funds?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge...... (read more)
10 Battered Biotech Stocks That Hit 52-Week Lows Friday
The markets have been strong over the past two weeks, bucking expectations that Britain's exit from the European Union would lead to a medium-term malaise in the market. That has included the Nasdaq,...... (read more)
Hedge Funds’ Favorite Stocks That Have RSI’s Under 30
Retail investors and larger-scale investors such as hedge funds are constantly on the lookout for cheap and oversold stocks that are expected to see fresh buying coming in. Battered stocks with heavy...... (read more)
J M Smucker Co (SJM) Registers Noteworthy Cluster of Insider Selling, Plus Four Other Companies with Notable Insider Trading Activity
Is insider trading behavior a good barometer for future stock performance? Yes and no! And let me explain why. Past research concludes that insider purchases indeed tend to outperform broader market benchmarks...... (read more)
Why Tyson Foods, Fitbit, and Three Other Stocks Are Down As Major Indices Are in Green
U.S. markets are trading up in the first day of the week, helped by Janet Yellen’s speech, in which she reiterated the plans to raise the interest rates, although she avoided to give a timeline on...... (read more)
Elite Hedge Funds Make Bigger Moves Into These 2 Stocks
Neal C. Bradsher's Broadwood Capital revealed in a recent Form 4 filing with the SEC that it has purchased an additional 2.43 million shares of BioTime, Inc. (NYSEMKT:BTX) in a registered direct offering...... (read more)
Mirati Therapeutics Inc. (MRTX): Baker Bros. Advisors Increases Stake in Growing Stock
Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics, Inc. (NASDAQ:MRTX). According to the 13D Form filed...... (read more)
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio. One of the companies involved is La Jolla Pharmaceutical Company (OTCBB:LJPCD...... (read more)
Billionaire Hedge Funds
